# Zachariah DeFilipp

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zachariah-defilipp/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,146 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 44 |
| i10-index | 116 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5041335047 |
| ORCID iD | 0000-0002-7994-8974 |
| Works | 297 |

## Researcher papers

- [Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant](https://scholariq.org/papers/drug-resistant-i-e-coli-i-bacteremia-transmitted-by-fecal-microbiota-transplant/)
- [Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study](https://scholariq.org/papers/belumosudil-for-chronic-graft-versus-host-disease-after-2-or-more-prior-lines-of/)
- [Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma](https://scholariq.org/papers/tisagenlecleucel-car-t-cell-therapy-in-secondary-cns-lymphoma/)
- [Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity](https://scholariq.org/papers/third-party-fecal-microbiota-transplantation-following-allo-hct-reconstitutes/)
- [Secondary solid cancer screening following hematopoietic cell transplantation](https://scholariq.org/papers/secondary-solid-cancer-screening-following-hematopoietic-cell-transplantation/)
- [Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease](https://scholariq.org/papers/indoles-derived-from-intestinal-microbiota-act-via-type-i-interferon-signaling/)
- [Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy](https://scholariq.org/papers/standardizing-definitions-of-hematopoietic-recovery-graft-rejection-graft/)
- [Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium](https://scholariq.org/papers/nonrelapse-mortality-among-patients-diagnosed-with-chronic-gvhd-an-updated/)
- [Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial](https://scholariq.org/papers/safety-and-efficacy-of-tisagenlecleucel-in-primary-cns-lymphoma-a-phase-1-2/)
- [Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease](https://scholariq.org/papers/axatilimab-in-recurrent-or-refractory-chronic-graft-versus-host-disease/)
- [Intravenous iron replacement for persistent iron deficiency anemia after Roux-en-Y gastric bypass](https://scholariq.org/papers/intravenous-iron-replacement-for-persistent-iron-deficiency-anemia-after-roux-en/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.